Levothyroxine taken at the right dose does not cause dementia. The concern that has surfaced in recent research is more specific: when levothyroxine doses push thyroid hormone levels too high, creating a state of medication-induced excess, dementia risk appears to rise. The drug itself is not the villain; overtreatment is. That distinction matters because levothyroxine is one of the most commonly prescribed medications worldwide, and the emerging evidence suggests that keeping the dose well-calibrated protects the brain rather than harming it.
The Overtreatment Problem
The study that sparked the most alarm was a large analysis published in JAMA Internal Medicine. Researchers followed patients on levothyroxine and found that those whose doses were high enough to suppress their TSH (thyroid-stimulating hormone) below normal had a meaningfully higher rate of new cognitive disorder diagnoses. About 7.2% of patients on excessively high doses received a dementia-related diagnosis during follow-up, compared with lower rates among those with well-controlled levels.1JAMA Internal Medicine. Exogenous Subclinical Hyperthyroidism and the Risk of Cognitive Decline The researchers noted that cognitive decline had already been linked to the body producing too much thyroid hormone on its own, but this study extended that finding to people getting too much from their medication.
A suppressed TSH essentially signals that the body is swimming in more thyroid hormone than it needs. It does not mean the levothyroxine tablet is toxic. It means the dose has pushed the patient into a biochemical state that resembles hyperthyroidism, where cognitive risks are well-documented. In many cases, the fix is simply a dose reduction and closer monitoring.
What Large Reviews Say About Thyroid Disorders and Dementia
If you step back from levothyroxine specifically and look at thyroid conditions broadly, the picture gets clearer. A systematic review pooling results from multiple meta-analyses found that hyperthyroidism carried an increased dementia risk, and subclinical hyperthyroidism carried an even larger one.2PubMed Central. The Association of Thyroid Disease with Risk of Dementia and Cognitive Impairment: A Systematic Review Hypothyroidism, on the other hand, was not linked to increased dementia risk in that same pooled analysis. A separate meta-analysis actually found that overt hypothyroidism was associated with a lower risk of dementia overall and a lower risk of Alzheimer’s disease specifically.3PubMed Central. Thyroid dysfunction and risk of different types of dementia: A systematic review and meta-analysis
This may seem counterintuitive. People with untreated hypothyroidism often feel foggy and forgetful, so how could that condition be associated with lower long-term dementia rates? The answer likely lies in the difference between the temporary cognitive symptoms of low thyroid hormone and the structural brain changes that lead to true dementia. Chronic excess thyroid hormone appears to do more lasting damage than chronic deficiency, at least when it comes to the irreversible forms of cognitive decline that get classified as dementia.
Subclinical hypothyroidism sits in an ambiguous zone. One meta-analysis found a significantly elevated risk of dementia only in people younger than 75 with the condition, and the risk correlated with how high their TSH levels were. When the researchers pooled all age groups together, the association was no longer statistically significant.4The Journal of Clinical Endocrinology & Metabolism. Subclinical Hypothyroidism and Cognitive Impairment: Systematic Review and Meta-Analysis That age split is a recurring theme in this field and hints that the relationship between thyroid function and cognition behaves differently across life stages.
Free T4 as a Warning Signal
TSH is the lab value most people know, but free T4, the active thyroid hormone circulating in the blood, may be a more direct indicator of what the brain is experiencing. A meta-analysis of eleven studies found that each standard-deviation increase in free T4 was associated with a higher risk of dementia, even when TSH looked normal.5Scientific Reports. Higher FT4 or TSH below the normal range are associated with increased risk of dementia: a meta-analysis of 11 studies The Rotterdam Study, one of the largest prospective investigations of thyroid function and brain health, confirmed a similar pattern: higher free T4 predicted dementia independent of other known risk factors.6PubMed. Thyroid function and the risk of dementia: The Rotterdam Study
In a cohort of older men followed for several years, those who eventually developed dementia had higher baseline free T4 levels than those who remained cognitively intact. After the researchers controlled for age, education, and other health factors, each unit increase in free T4 was associated with roughly an 11% increase in dementia risk. Men in the higher free T4 quartiles had about 1.8 times the risk of dementia compared with those in the lowest quartile.7The Journal of Clinical Endocrinology & Metabolism. Higher Free Thyroxine Levels Predict Increased Incidence of Dementia in Older Men: The Health In Men Study
This matters for levothyroxine users because the drug works by raising free T4. If your dose is calibrated correctly, free T4 stays in a healthy range. If the dose is too high, free T4 creeps up, and the brain begins to experience the same kind of excess that endogenous hyperthyroidism would produce. Brain imaging research underscores the point: in younger people, higher free T4 was associated with larger brain and white-matter volumes, but in older individuals, the relationship reversed, with higher free T4 linked to smaller total brain volume and white-matter changes.8Neurobiology of Aging. Age-dependent association of thyroid function with brain morphology and microstructural organization: evidence from brain imaging
How Excess Thyroid Hormone Affects the Brain
The pathways by which too much thyroid hormone harms brain tissue have been mapped in increasing detail. Research points to oxidative stress, energy-production breakdowns inside cells, overactivation of the brain’s excitatory signaling, and chronic low-grade inflammation as the main culprits.9Academic Press. Hormones in Neuroscience These are not subtle effects visible only under a microscope. They interfere with the connections between brain cells, disrupt the chemical messengers that neurons rely on, and gradually degrade the tissue needed for memory and reasoning.
There is also a vascular angle. Both very low and very high TSH levels have been associated with atrial fibrillation, which itself is a well-established risk factor for cognitive decline. Irregular heart rhythms can reduce blood flow to the brain and cause small clots or inflammation that accumulate over years.10The Journal of Clinical Endocrinology & Metabolism. Treatment of Hypothyroidism That Contains Liothyronine is Associated With Reduced Risk of Dementia and Mortality For patients on levothyroxine who are being pushed into a mildly hyperthyroid state, the cardiovascular pathway may be just as important as the direct neurological one.
When Levothyroxine Protects Cognition
The flip side of the overtreatment risk is that levothyroxine at the correct dose genuinely helps the brain. Untreated hypothyroidism leads to cognitive problems including impaired memory and difficulty concentrating. These deficits are well-documented by both clinical testing and brain imaging, and importantly, they are largely reversible once treatment restores normal thyroid levels.11PubMed Central. Psychiatric and cognitive manifestations of hypothyroidism
A review of the evidence found that levothyroxine helps reverse the dementia-like cognitive impairment associated with thyroid dysfunction, reducing the severity of neuropsychiatric symptoms in the process.12PubMed Central. Does Hormone Supplementation With Levothyroxine Improve Hypothyroid Impaired Cognitive Dysfunction? In a specific high-risk group, women with both hypothyroidism and atrial fibrillation, those who were prescribed levothyroxine showed a substantially lower risk of developing dementia compared with untreated women, even after adjusting for age and other health conditions.13PubMed Central. Effect of Levothyroxine Treatment on Incident Dementia in Adults with Atrial Fibrillation and Hypothyroidism
So the evidence runs in two directions at once. Properly dosed levothyroxine appears to protect cognition in people who need it. Excessively dosed levothyroxine appears to raise dementia risk. The drug is the same molecule in both scenarios. The difference is the dose and the resulting hormone levels.
Why Dosing Gets Trickier With Age
TSH levels naturally drift upward as people age, which means what looks like a mildly elevated TSH in a 75-year-old may simply be that person’s normal physiology. When clinicians treat these numbers aggressively, trying to push TSH back into the range seen in younger adults, they risk overtreatment. This matters because older adults are precisely the population most vulnerable to the brain effects of excess thyroid hormone, as the imaging data on free T4 and brain volume described above demonstrates.8Neurobiology of Aging. Age-dependent association of thyroid function with brain morphology and microstructural organization: evidence from brain imaging
Expert reviews of hypothyroidism management in the elderly consistently emphasize the need to verify the diagnosis carefully and to tolerate mildly higher TSH values in older patients rather than chasing a younger person’s target. The risk of overtreatment, including potential cognitive harm, must be weighed against the often modest benefits of normalizing TSH in someone whose mild elevation may be physiologically appropriate.14PubMed Central. Hypothyroidism in the Elderly: Who Should Be Treated and How? Thyroid status should be reassessed periodically, because the dose someone needed at age 60 may be too much at age 78.
What FDA Adverse Event Reports Show
An analysis of the FDA’s adverse event reporting database (FAERS) looked specifically at reports of dementia symptoms associated with exogenous thyroid hormones. Over the years examined, dementia accounted for roughly 3% to 6% of reported adverse reactions in patients on these medications. The signal was consistent across sex, age, and the medical indication for which the thyroid hormone was prescribed. Interestingly, the median time between starting treatment and the onset of dementia symptoms was only about a week, and the median total treatment duration was around 40 days. No clear dose-response relationship emerged.15Annals of Pharmacotherapy. Exploring the Link Between Exogenous Thyroid Hormones and Dementia Symptoms: A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System
That short onset window deserves a note of caution before you read too much into it. FAERS reports are voluntary, unverified, and cannot prove causation. The rapid onset suggests these reports may capture transient confusion or delirium related to starting a new medication, medication errors, or unmasking of a pre-existing cognitive condition rather than the kind of slowly progressive dementia that develops over years. Still, the signal is real enough to merit clinical attention, especially when starting levothyroxine in an older patient who may already have borderline cognitive function.
Autoimmune Thyroid Disease as a Cognitive Mimic
There is a rare condition called Hashimoto’s encephalopathy, more formally known as steroid-responsive encephalopathy associated with autoimmune thyroiditis. It causes confusion, memory loss, personality changes, and sometimes seizures, and it can look remarkably like dementia in older adults. Diagnosis is tricky because the symptoms overlap so heavily with both dementia and delirium, and only about 51 cases in patients aged 65 and older had been reported in the literature as of recent counts.16Journal of Community Hospital Internal Medicine Perspectives. Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis: A Case Fulfilling Definite Graus Criteria
The relevance here is that someone with autoimmune thyroid disease who is already on levothyroxine might develop cognitive symptoms and assume the medication is causing them. In reality, the autoimmune process itself may be attacking the brain. Hashimoto’s encephalopathy typically responds well to corticosteroids, not to levothyroxine dose adjustments. When cognitive symptoms appear suddenly in someone with known thyroid autoimmunity, testing for thyroid antibodies and considering this rare diagnosis can prevent months of misattributed blame and inappropriate dose changes.
Brain Imaging in Hypothyroidism
Neuroimaging studies have added texture to our understanding of how untreated hypothyroidism affects brain structure. A study comparing brain scans of patients with overt hypothyroidism to healthy controls found significant disruptions in the efficiency of white-matter networks, the “wiring” that connects different brain regions. Efficiency was reduced in areas including the frontal lobe, the parahippocampal region important for memory, and the amygdala, which is involved in emotion processing.17Endocrine Connections. Alterations of brain white matter network topological properties in overt hypothyroidism These findings show that leaving hypothyroidism untreated comes with its own cognitive costs, reinforcing the idea that the drug itself is not the enemy.
The brain’s relationship with thyroid hormone also extends to development. Mapping studies of thyroid hormone activity in the human brain show that the hormone is active in regions critical for higher-order thinking, including the cerebral cortex and hippocampus.18PubMed Central. Mapping Thyroid Hormone Action in the Human Brain The brain needs thyroid hormone throughout life, which explains both why deficiency causes problems and why excess does too. The therapeutic window is real, and staying inside it is the whole game.
Does Adding T3 Help Cognition?
Some patients and practitioners have wondered whether combining levothyroxine (T4) with liothyronine (T3) might offer cognitive advantages over standard T4-only therapy. A clinical trial comparing the two approaches found no difference in mood or cognitive performance between the combination and T4 alone.19PubMed. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism However, a separate study looking at real-world outcomes found that treatment regimens containing liothyronine were associated with reduced dementia risk and lower mortality compared with levothyroxine alone.10The Journal of Clinical Endocrinology & Metabolism. Treatment of Hypothyroidism That Contains Liothyronine is Associated With Reduced Risk of Dementia and Mortality These results pull in different directions, and the question of T3 supplementation remains unsettled. The key point is that the type of thyroid hormone preparation matters less than whether the resulting hormone levels stay within healthy bounds.
Drug Interactions Worth Knowing About
Older adults on levothyroxine are frequently taking several other medications, and levothyroxine is a narrow-therapeutic-index drug, meaning small shifts in how much gets absorbed or metabolized can have outsized effects on hormone levels. A population-based study of potential drug interactions in older adults found that levothyroxine was among the most commonly involved medications in interactions that could have serious health consequences.20Wiley Online Library. Potential drug-drug interactions in older adults: A population-based study
Calcium supplements, iron, and antacids can all reduce levothyroxine absorption if taken at the same time. Certain cholesterol-lowering medications can interfere as well. When absorption drops, TSH rises, and a clinician who sees the elevated TSH may increase the levothyroxine dose. If the patient later stops the interfering medication or changes when they take it, the higher levothyroxine dose may suddenly produce excess thyroid hormone. This seesaw effect is one practical mechanism by which patients end up overtreated without anyone making an obvious error.
ApoE4, Thyroid Deficiency, and a Mouse Model
Some of the most intriguing emerging research connects thyroid function to the ApoE4 gene variant, the strongest known genetic risk factor for Alzheimer’s disease. In aged mice engineered to carry human ApoE4, thyroid deficiency increased the transport of ApoE4-laden particles from the liver into the brain. When these mice were treated with levothyroxine, the amount of ApoE4 reaching the brain dropped substantially.21PubMed Central. Ageing related thyroid deficiency increases brain-targeted transport of liver-derived ApoE4-laden exosomes leading to cognitive impairment This is animal research and a long way from clinical recommendations, but it raises a provocative possibility: in people who carry the ApoE4 variant, maintaining adequate thyroid hormone levels through treatment might be even more important for brain health than in the general population. If confirmed in human studies, it would add another layer to the argument that proper levothyroxine dosing is protective rather than harmful.